EP1487984A4
Dna vaccines encoding cea and a cd40 ligand and methods of use thereof
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 28 February 2023, 3.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
12 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12
Every citation, both waysCites: the store holds 0 of 1
| Reference | Relation | Cited during |
|---|---|---|
| XIANG R ET AL: "DNA vaccines encoding a CD40 ligand-trimer-CEA chimeric protein combined with boosts of an antibody-IL2 fusion protein markedly enhanced tumor protective immunity in CEA-transgenic mice", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 42, March 2001 (2001-03-01), & 92ND ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH; NEW ORLEANS, LA, USA; MARCH 24-28, 2001, pages 698 - 699, XP001207347, ISSN: 0197-016X | Non-patent | Search report |
| GURUNATHAN S ET AL: "CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge", JOURNAL OF IMMUNOLOGY 01 NOV 1998 UNITED STATES, vol. 161, no. 9, 1 November 1998 (1998-11-01), pages 4563 - 4571, XP002345704, ISSN: 0022-1767 | Non-patent | Search report |
| CLARKE PATRICK ET AL: "Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy", CANCER RESEARCH, vol. 58, no. 7, 1 April 1998 (1998-04-01), pages 1469 - 1477, XP002345705, ISSN: 0008-5472 | Non-patent | Search report |
| See also references of WO 03074712A1 | Non-patent | Search report |
18 members in 13 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 90238 | United States of America | – | |
| 9023802 | United States of America | A | |
| 9023802 | United States of America | A | |
| 0306295 | United States of America | W | |
| 0306295 | United States of America | W | |
| 90238 | – | – | – |
| US20020090238 | – | – | – |
| US2003006295 | – | – | – |
| WO2003US06295 | – | – | – |
Members18
| Document | Office | Kind | |
|---|---|---|---|
| CA2477647A1 | Canada | A1 | |
| WO03074712A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003213653A1 | Australia | A1 | |
| US2003176377A1 | United States of America | A1 | |
| KR20040089696A | Republic of Korea | A | |
| MXPA04008475A | Mexico | A | |
| EP1487984A1 | European Patent Office (EPO) | A1 | |
| BR0308101A | Brazil | A | |
| RU2004129331A | Russian Federation | A | |
| US6923958B2 | United States of America | B2 | |
| CN1650015A | China | A | |
| PL373607A1 | Poland | A1 | |
| JP2005526750A | Japan | A | |
| EP1487984A4This record | European Patent Office (EPO) | A4 | |
| US2005287123A1 | United States of America | A1 | |
| ZA200406991B | South Africa | B | |
| US7279464B2 | United States of America | B2 | |
| AU2003213653B2 | Australia | B2 |
7 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1487984
- Publication, DOCDB
- 1487984
- Publication, EPODOC
- EP1487984
- Application
- 3711340
- Application, DOCDB
- 03711340
- Application, EPODOC
- EP20030711340
Titles3
- German
- CEA UND EINEN CD40-LIGANDEN CODIERENDE DNA-IMPFSTOFFE UND VERFAHREN ZUR VERWENDUNG DAVON
- English
- DNA VACCINES ENCODING CEA AND A CD40 LIGAND AND METHODS OF USE THEREOF
- French
- VACCINS A BASE D'ADN CODANT L'ACE ET UN LIGAND CD40, ET PROCEDES D'UTILISATION CORRESPONDANTS
Classification
- CPC, 13
- C07K14/70503
- A61K48/00
- A61K2039/522
- A61K2039/523
- A61K2039/53
- A61K2039/55516
- A61K2039/55533
- C07K14/70575
- A61P35/00
- A61K39/001182
- A61K31/7088
- C12N15/79
- C12N15/11
- IPC, 16
- C12N15 09
- A61J1 14
- A61K35 74
- A61K35 76
- A61K35 761
- A61K35 763
- A61K38 00
- A61K38 16
- A61K39 00
- A61K39 39
- A61K48 00
- A61P35 00
- C07K14 705
- C12N15 12
- C12N15 19
- C12N15 63
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- Romania